(Q42669075)

English

Safety and efficacy of first-line bevacizumab-based therapy in advanced non-squamous non-small-cell lung cancer (SAiL, MO19390): a phase 4 study.

scientific article published on 23 July 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20650686%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Safety and efficacy of first-line bevacizumab-based therapy in advanced non-squamous non-small-cell lung cancer (SAiL, MO19390): a phase 4 study (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20650686%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20650686%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20650686%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

5

object named as

Janessa Laskin

1 reference

Europe PubMed Central

8 February 2020

Daniil Stroyakovskiy

1 reference

ORCID Public Data File 2021

author name string

Lucio Crinò

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20650686%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Eric Dansin

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20650686%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Frank Griesinger

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20650686%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Nick Pavlakis

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20650686%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Daniel Stroiakovski

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20650686%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Nick Thatcher

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20650686%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Chun-Ming Tsai

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20650686%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Caicun Zhou

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20650686%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

publication date

23 July 2010

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20650686%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Lancet Oncology Commission

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20650686%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20650686%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20650686%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

733-740

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20650686%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Global cancer statistics, 2002

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970151-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970151-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase III trial of cisplatin plus gemcitabine with either placebo or bevacizumab as first-line therapy for nonsquamous non-small-cell lung cancer: AVAil

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970151-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Overall survival with cisplatin-gemcitabine and bevacizumab or placebo as first-line therapy for nonsquamous non-small-cell lung cancer: results from a randomised phase III trial (AVAiL)

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970151-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970151-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Hypertension as a surrogate marker for the activity of anti-VEGF agents

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970151-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970151-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Bevacizumab safety in patients with central nervous system metastases.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970151-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Taxane-platinum combinations in advanced non-small cell lung cancer: a review

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970151-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Rapid chemotherapy-induced acute endothelial progenitor cell mobilization: implications for antiangiogenic drugs as chemosensitizing agents

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970151-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1470-2045(10)70151-0

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20650686%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20650686%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42669075&oldid=1580781232"